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ABSTRACT 
Objective 
Intensive care (ICU) survivors frequently report reduced health-related quality of life 
(HRQoL), but the relative importance of pre-illness versus acute illness factors in survivor 
populations is not well understood. We aimed to explore HRQoL trajectories over 12 months 
following ICU discharge, patterns of improvement or deterioration over this period, and the 
relative importance of demographics (age, gender, social deprivation), pre-existing health 
(functional comorbidity index (FCI)), and acute illness severity (APACHE II score, ventilation 
days) as determinants of HRQoL and relevant patient-reported symptoms during the year 
following ICU discharge.   
Design 
Nested cohort study within a previously published randomised controlled trial.    
Setting 
Two ICUs in Edinburgh, Scotland. 
Patients 




Measurements and Main Results 
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We prospectively collected data for age, gender, social deprivation (Scottish Index of 
Multiple Deprivation), pre-existing comorbidity (Functional Comorbidity Index), APACHE II 
score, and days of mechanical ventilation (MV). HRQoL (Medical Outcomes Study Short Form 
version 2 (SF12 v2) physical (PCS) and mental (MCS) components scores) and patient-reported 
symptoms (appetite, fatigue, pain, joint stiffness and breathlessness) were measured at 3, 6, 
and 12 months.  Mean PCS and MCS were reduced at all time points with minimal change 
between 3 and 12 months. In multivariable analysis increasing pre-ICU comorbidity count was 
strongly associated with lower HRQoL (PCS =-1.56 (-2.44 to -0.68); p=0.001; MCS = -1.45 (-
2.37 to -0.53); p=0.002) and more severe self-reported symptoms. In contrast, APACHE II 
score and MV days were not associated with HRQoL.  Older age ( 0.33 (0.19 to 0.47); p 
<0.001) and lower social deprivation ( 1.38 (0.03 to 2.74); p=0.045) were associated with 
better MCS HRQoL.   
Conclusions 
Pre-existing comorbidity count, but not severity of ICU illness, are strongly associated 
with HRQoL and physical symptoms in the year following critical illness.  
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INTRODUCTION 
ICU survivors report poor health-related quality of life (HRQoL) in the months and 
years following hospital discharge.(1–3) Rehabilitation trials testing numerous interventions 
during and after ICU have been ineffective at improving HRQoL and other measures of health 
status.(4–10) (11) When positive effects have been described, they have been limited to 
HRQoL sub-domains at time points that are of uncertain clinical significance.(5)(6)(7)(8)(9, 10) 
Given these results, it is reasonable to assume that the interventions tested are 
ineffective and that greater knowledge of the underlying pathophysiology and the 
approaches used in future trials should be research priorities.  However, it is also possible that 
the heterogeneous ICU populations included in trials include subgroups of patients that 
respond differently to interventions. Specifically, some patients may have refractory 
functional impairments, perhaps as a result of pre-ICU health that cannot be modified. These 
patients might mask important positive effects in other sub-populations.(12)(13) 
The post-intensive care syndrome (PICS) conceptualises the direct effects of critical 
illness on physical and mental health, but the importance of pre-existing illness relative to the 
acute ‘hit’ of critical illness remains poorly understood. An improved understanding of the 
determinants of long term health following critical illness could improve the evaluation of 
interventions designed to improve recovery. The inclusion of HRQoL as a  core outcome 
following critical illness highlights the need for a detailed understanding of this and related 
outcome measures.(14)  
In a randomised trial of post-intensive care hospital based rehabilitation we recently 
found no effect on measures on functional status, HRQoL, or physical symptoms during 12 
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months follow-up.(5)(15).  We hypothesised that this lack of effect might relate in part to pre-
critical illness factors,  a ‘signal to noise’ issue, whereby the ‘noise’ of non-modifiable pre-
existing health may have dominated any ‘signal’ of effect in the trial. Our aims in this nested 
cohort study of the trial data were to describe trajectories of HRQoL over 12 months following 
ICU discharge; to identify patients whose HRQoL either deteriorated or failed to improve 
between 3 months and 12 months ICU discharge;  to explore the relative importance of 
patient demographics, pre-critical illness health status, and critical illness severity as 
determinants of individual HRQoL trajectory after ICU discharge; and, to assess the 
consistency of associations in other patient centred outcomes we collected in the trial.    
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MATERIALS AND METHODS 
This was a cohort study nested within a randomised trial of increased hospital-based 
physical rehabilitation and information provision for ICU survivors who required ≥48 hours of 
continuous mechanical ventilation (MV).  Detailed trial inclusion/exclusion criteria have been 
published previously.(16)  Participants received either usual care or the intervention. As no 
treatment effects for HRQoL or patient-reported symptoms were found, a single cohort was 
constructed from the trial database to address the following research questions:  What were 
the cohort level trajectories of PCS and MCS between 3 months and 12 months after ICU 
discharge? What proportions of patients showed no clinically important improvement of PCS 
and MCS between 3 and 12 months? Which factors were most strongly associated with 
HRQoL at 6  and 12 month post-ICU discharge? Which factors were most strongly associated 
with patient-reported symptoms at 12 months post ICU discharge?  This study was approved 
by the Scotland A Research Ethics committee. Participants or their surrogate decision makers 
provided written informed consent. 
Outcome measures  
For HRQoL, the Medical Outcomes Study Short Form 12 version 2 (SF12v2), including 
the Physical Component Score (PCS; range 0-100) and Mental Component Score (MCS; range 
0-100) calculated using US-derived co-efficients.(17)   Patient-reported physical symptoms of 
appetite, fatigue, pain, joint stiffness and breathlessness were measured on a visual analogue 
scale of 10cm in length ranging from 0 (no symptoms at all) to 10 (worse symptoms 
imaginable). As per the trial protocol, the trial aimed to measure these outcomes for all 
surviving patients at 3, 6, and 12 months post-randomisation. 
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Exposures 
We selected variables from the trial database to best represent demographics, pre-
existing comorbidity burden, and critical illness severity and duration. The number of 
variables did not exceed recommended maximums to prevent overfitting.(18) 
Patient characteristics: We used age, gender, and social deprivation. Social 
deprivation was measured using the Scottish Index of Multiple Deprivation (SIMD), a post-
code based deprivation ranking of each of 6,976 geographical areas within Scotland. These 
are described in quintiles ranging from 1 (most deprived) to 5 (least deprived).(19)  
Pre-existing comorbidity burden: We used the Functional Comorbidity Index (FCI) 
assessed at study entry by review of medical records, and by discussion with patients and 
families. This validated measure is based on 18 comorbidity items with higher scores 
indicating more comorbidities.(20, 21)  
Features of acute illness severity: We used the APACHE II score,(22) and days of MV.  
Immediate post-ICU discharge physical status: We measured the Rivermead Mobility 
Index (RMI), and the physical assessment of the Subjective Global Assessment of Nutrition 
(SGA) at enrolment (ICU discharge). The RMI is a hierarchical mobility index ranging from 0 
(bedridden) to 15 (able to run).(23) The SGA is a subjective clinical assessment of nutritional 
status based on signs of fat loss, muscle wasting, and oedema measured on a scale of 1 (well 
nourished) to 3 (severely malnourished).(24)  
Analysis 
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Statistical analysis was conducted using SPSS (IBM Corp. Released 2012. SPSS Statistics 
for Mackintosh, version 21·0, Armonk, NY; or Released 2016. SPSS Statistics for Mackintosh, 
version 24·0, Armonk, NY).  Sankey plots were created using SankeyMATIC 
(http://sankeymatic.com/build/). 
Cohort level trajectories of PCS and MCS between 3 months and 12 months after ICU 
discharge 
PCS and MCS trajectories were plotted for individual patients.   Mean (95% confidence 
interval (CI)) PCS and MCS were plotted to summarise cohort level trajectories.  Comparison 
between PCS and MCS at 3 and 12 months was made using paired t tests.  
Proportions of patients that showed no clinically important improvement of PCS and MCS between 
3 and 12 months  
We defined a minimum clinical important difference (MCID) in PCS and MCS as >±5 
points (consistent with published literature) and used Sankey plots to illustrate groups of 
patients that improved, deteriorated, or remained static between 3 months and 12 
months.(25) To explore floor and ceiling effects in this analysis, we re-plotted the Sankey plots 
for each quartile of  HRQoL score at baseline.    
Factors most strongly associated with HRQoL at 6 and 12 months after ICU discharge 
We used bivariate unadjusted linear regression to examine univariate associations 
between the exposure variables and HRQoL at 6 and 12 months following ICU discharge, and 
multivariable linear models to explore the relative importance of each variable. For each 
outcome variable, two models were fitted.  The first model excluded physical status measured 
at ICU discharge (SGA and RMI at ICU discharge; model 1) on the assumption that these 
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variables encompassed the effects of the acute illness and the pre-morbid physical function 
and would not add additional information.  As a sensitivity analysis, the second model (model 
2) included the RMI and SGA nutrition at ICU discharge to explore the possibility that 
immediate post-ICU physical status might more strongly account for long-term HRQoL.   RMI 
was log transformed (Ln(1+RMI)) prior to analysis. 
Risk factors most strongly associated with patient-reported symptoms at 12 months post ICU 
discharge 
To assess whether consistent associations were also observed when patient 
symptoms were used in place of HRQoL, we repeated the regression analysis for each of the 
5 patient-reported symptoms (appetite, fatigue, pain, joint stiffness, and breathlessness) at 
12 months. 
Missing data 
We undertook a complete case analysis.  To assess whether cases with missing data 
were likely to be different from those included, baseline characteristics were compared 
between missing and included cases.  
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RESULTS 
Of the 240 patients enrolled in the RECOVER study, 228, 220, and 218 patients were 
alive at 3, 6, and 12 months respectively (study flow diagram in figure E1 in the electronic 
supplement) and HRQoL data was available for 197/228 (86%), 165/220 (75%) and 155/218 
(71%) of these survivors.  Baseline characteristics are shown in table 1.    Patients with missing 
data were similar to included patients in respect of pre-existing heath, baseline 
demographics, and severity of illness (see online electronic supplement; table E8).   
Cohort level trajectories of PCS and MCS between 3 months and 12 months after ICU discharge 
 Individual patient plots showed marked heterogeneity over time for both HRQoL 
components (see figures E2-E3 in the electronic supplement).   At cohort level, mean PCS was 
reduced compared to population norms (where population norm is 50 on each scale) at all 
time points (Figure 1(A) and table 2). The PCS increased by a statistically significant but 
clinically small amount between 3 months and 12 months, with an overall change less than 
the pre-defined MCID of 5 (mean difference (95% CI):  2.3 (0.6 to 3.9); p=0.006). MCS was also 
reduced compared to population norms but higher than the PCS at each time point. Mean 
MCS did not change between 3 and 12 months (Figure 1(B) and table 2) (mean difference 
(95% CI): 0.2 (-1.8 to 2.1); p=0.87). These cohort level data suggested plateauing of both 
measures by 3 months, with little subsequent change. 
Proportions of patients that showed no clinically important improvement of PCS and MCS 
between 3 and 12 months 
 
 
  9 
 147 patients had complete PCS and MCS data at 3 and 12 months.   Ninety-four 
patients (63%) had no clinically significant improvement in PCS between 3 and 12 months 
(table E1 (electronic supplement) and figure 1 (Panel C)).  One-hundred and one patients 
(69%) had no clinically significant improvement in MCS (figure 1 (Panel D)). In the sensitivity 
analysis, 50%, 58%, 70% and 77% of patients in quartiles 1 (lowest HRQoL), 2, 3, and 4 of PCS 
at baseline had no clinically important improvement; 44%, 66%, 65% and 97%  of patients in 
quartiles 1, 2, 3, and 4 of MCS at baseline had no clinically important improvement. 
Risk factors most strongly associated with HRQoL at 6 and 12 months after ICU discharge 
 Adjusted model 1 co-efficients (excluding RMI and SGA) at the 6-month time point are 
shown in table 3.  Unadjusted co-efficients and adusted model 2 co-efficients (including RMI 
and SGA) are shown in table E2 (6 months) and table E3 (12 months) in the electronic 
supplement. In the adjusted models, a higher comorbidity count was strongly associated with 
lower (worse) PCS and MCS at 6 and 12 months.  Critical illness related variables were not 
associated with either PCS or MCS at either time point.  Examining other patient 
characteristics, there was a strong association observed between increasing age and higher 
(better) MCS at 6  and 12 months. There was also an association between higher social class 
(higher SIMD quintile (lower deprivation)) and higher (better) MCS at 6 months but not 12 
months.  In the sensitivity analyses, the inclusion of measures of early post-ICU discharge 
physical status (RMI and nutrition) did not significantly alter the observed effect sizes  
To illustrate the impact of increasing physical comorbidity on HRQoL trajectory, we 
plotted HRQoL trajectories according to sub-groups of patients with different comorbidity 
counts prior to ICU admission.  This clearly showed that as the numbers of comorbidities 
present pre-ICU increased, the PCS and MCS were lower during the 12 months following ICU 
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discharge and tended to follow a flatter trajectory indicating lack of improvement (figure 2 
and tables E4-6 (electronic supplement)). This was most marked for PCS.   
Risk factors most strongly associated with patient-reported symptoms 12 months post ICU 
discharge 
 Higher comorbidity count was independently associated with higher (worse) appetite, 
fatigue, pain, joint stiffness, and breathlessness symptom scores (table E7; online electronic 
supplement).  Increasing SIMD quintile (lower deprivation) was associated with lower pain 
scores.  Neither of the acute illness severity factors (APACHE II score or duration of MV) were 
associated with any of the symptoms.  The observed co-efficients were not affected by 
nutrition and baseline RMI when tested in the sensitivity analysis, even though RMI and 
nutrition were associated with some of the symptom outcomes:  Lower RMI (poorer mobility) 
at baseline was associated more severe joint stiffness during follow up. Poorer nutritional 
status on subjective assessment was associated with higher pain and fatigue scores during 
follow up. 
DISCUSSION 
We report a secondary analysis of trial data exploring trajectories and determinants 
of HRQoL and physical symptoms during 12 months of follow-up after critical illness. At cohort 
level PCS and MCS were below population means and did not change by a clinically important 
amount between 3 months and 12 months.  Specifically, around two thirds of patients 
showed no clinically important improvement in MCS and PCS (≥5 points) between 3 and 6 
months, even among the quartiles with lower HRQoL at 3 months.  In multivariable analysis, 
pre-exisiting comorbidity count emerged as the most important predictor of long term HRQoL 
outcome. Patient demographics, measures of critical illness severity, and early post critical 
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illness physical status were not significant predictors of long term physical HRQoL once pre-
existing comorbidity was taken into account. Recovery of physical function was most 
consistent in patients without pre-ICU comorbidity or with lower co-morbidity counts. The 
almost identical findings for a range of patient reported symptom scores reflecting patient 
health and well-being provide indirect validation for these findings. 
Strengths of our study include the use of an externally valid prospectively included 
sample of ICU survivors from a randomised trial, but caution is still advised when 
extrapolating to other ICU cohorts. Exposures and outcomes were measured prospectively 
using valid tools.  In particular, comorbidity count was collected prospectively in all patients 
at the time of enrolment by careful review of medical notes, and direct questioning of patient 
relatives; therefore, the accuracy of the FCI comorbidity is likely to be high.  Assessment of 
illness severity factors was complete, and used measures that are known to affect short-term 
ICU outcomes.  
Several limitations should be noted. A  power calculation was not conducted making 
it possible (but unlikely given the small confidence intervals) that small sample size could 
explain the lack of association between critical illness severity and HRQoL. Missing data may 
have biased the analysis despite our included patients being similar to those without 
complete outcome data across all baseline variables measured. SF12v2 was used in 
preference to the more detailed SF-36 for pragmatic reasons (taking less time and 
concentration to complete) to reduce attrition bias, but may have reduced the resolution of 
our analysis. The strong relationship between severe subjective malnutrition and less severe 
physical symptoms is difficult to explain but could relate to the limitations of the SGA measure 
in oedematous post-ICU patients where signs of malnutrition may be masked by oedema. 
Finally, other factors such as social integration  and family support in the months following 
  12 
ICU discharge are known to be associated with HRQoL and may have been the cause of (or 
consequence of) reduced HRQoL in our patients.  We were unable to explore this further in 
our study.(26) 
 Previous work has shown that ICU survivors have reduced HRQoL with minimal change 
after ICU, especially after 3 months post hospital discharge(1–3). Our data furthers the 
understanding of patient HRQoL trajectories at population level by showing that between 3 
and 12 months only a minority have clinically important improvement, with the majority 
remaining static or deteriorating over time. Importantly, these patterns were evident 
irrespective of the HRQoL quartile at 3 months, with many patients in the lowest quartiles 
reporting no subsequent improvement. Previous studies have implied that incomplete long 
term recovery may be a direct consequences of critical illness, comprising the ‘post-intensive 
care syndrome’. However, most lacked reliable pre-critical illness comorbidity, HRQoL, or 
other data to assess the relative contribution of pre-existing health to post-ICU outcomes.  
Orwelius and colleagues used questionnaires administered to ICU patients surviving 6 months 
from ICU discharge to retrospectively assess pre-ICU health status, with a 59% response rate. 
Their analysis suggested pre-existing disease was a strong independent determinant of 
HRQoL outcomes, but was potentially subject to recall and response bias.(27) A more recent 
sub-study of patients aged 70 years or older, who participated in a larger cohort study of 
functional recovery but required an ICU admission, explored a range of potential 
determinants of return to pre-critical illness functional status. In this analysis, pre-ICU 
impairments of hearing and vision were strongly associated with poor functional outcome at 
6 months, but comorbidity count and ICU related factors were not.(28)  Our prospective study 
sampled a general mixed ICU population across all adult age groups, and provides strong 
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evidence for the importance of pre-ICU comorbidity as a major determinant of post-ICU 
HRQoL beyond the first 3 months post-ICU discharge.   
 Our findings add to a growing body of research highlighting pre-ICU health as a key 
determinant of important ICU outcomes including mortality(29) and healthcare resource use 
(30) in addition to functional recovery and HRQoL. This has implications for future trial design.  
In trials seeking to improve post-ICU HRQoL for example, more comorbid patients may have 
limited or no responsiveness to the trial intervention, which could mask important effects in 
less comorbid groups. In future trials and outcomes research we believe our data show that 
careful consideration of pre-existing health status is essential when HRQoL or similar patient-
centred measures are key long-term outcomes, as has been recently recommended.(14) 
These factors need to be considered when defining study populations, which baseline data to 
collect, and how statistical adjustment is undertaken during analyses. Failure to consider 
these issues may undermine power calculations and mask important clinical effects in less 
comorbid patients.(12)    
CONCLUSIONS 
In a prospectively studied sample derived from a post-ICU rehabilitation trial, HRQoL 
was reduced in ICU survivors. Many patients failed to experience clinically important 
improvement in HRQoL between 3 and 12 months. Pre-critical illness comorbidity rather than 
features of the critical illness were the strongest predictors of survivors’ HRQoL and self-
reported physical symptoms during the 3 to 12 months following ICU discharge.  
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Health-related quality of life trajectory between 3 and 12 months after ICU discharge. 
Panels A and B show cohort level data with mean (95% CI) for Physical Component Score (PCS) 
of the Short Form 12 version 2 (SF12v2) (A) and Mental Component Score (MCS) of SF12v2 
(B). Dashed lines indicate the population norm of 50 for both scores. Panels C and D show the 
subset of patient with SF12v2 measured at both 3 months and 12 months to demonstrate 
subgroups of patients that improved or deteriorated by more than the minimal clinical 
important difference (5 points) on each scale between 3 and 12 months. Plots are stratified 
by quartile of PCS (C) or MCS (D) at 3 months. Panels A and B: Whole cohort data. n at 3, 6 
and 12 months: 197, 165, and 155 respectively. Panels C and D: subset of patients with 




Health-related quality of life trajectory between 3 and 12 months after ICU discharge 
for patients with data at all time points. Panels show data for Physical Component Score (A) 
and Mental Component Score (B) stratified according to the number of baseline 
comorbidities. Mean (standard error of the mean). n=137. 
 
